GlobeStar Therapeutics Corp — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2023)

-$1.9M

Total Equity (FY2023)

-$1.4M

Cash Flows from Operating Activities (FY2023)

-$205.8K

Source: GlobeStar Therapeutics Corp 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.